However, in the HCC patient population, AFP-negative hepatocellular carcinoma (ANHC), i.e., AFP < 20 ng/mL at initial diagnosis, is an important type that causes many patients to lose early diagnosis and treatment and accounts for approximately 30-40% of patients [12]. The gene discussed is AFP; the disease is hepatocellular carcinoma.